Basis Concepts of Neuroepidemiology and Statistics. Part 2.

Francisco Aguilar Rebolledo; Servando J. Juárez Ocaña; Juan Manuel Mejía Aranguré; Martha Zanabria Salcedo

2004, Number 2

<< Back

Rev Med Inst Mex Seguro Soc 2004; 42 (2)

Basis Concepts of Neuroepidemiology and Statistics. Part 2.

Aguilar RF, Juárez OSJ, Mejía AJM, Zanabria SM

Full text

How to cite this article

Language: Spanish
References: 21
Page: 175-180
PDF size: 88.23 Kb.

ABSTRACT

In this article, we defined the concepts of the clinical trial, meta-analysis, and sensitivity and specificity of tests, and included brief information concerning evidence-based medicine. In addition, we described the most recent epidemiologic studies in brief with particular emphasis on those carried out at our setting.

REFERENCES

1. Ahlbom A, Staffan N. Fundamentos de epidemiología. Cuarta edición. México: Siglo XXI; 1993. p. 3-11.
2. Howe GR, Choi BCK. Methodological issues in case-control studies: validity and power of various design/strategies. Int J Epidemiol 1983;12:238-245.
3. Silva-García-de-la-Torre G, Huerta-Alvarado SG. Consideraciones metodológicas y análisis simple de los estudios transversales. Bol Med Hosp Infant Mex 1998;55:348-356.
4. Dos-Santos-Silva I. Epidemiología del cáncer: prin-cipios y métodos. Lyon, Francia; Agencia Internacio-nal de Investigación sobre el Cáncer; 1999. p. 173-225.
5. Aguilar-Rebolledo, et al. Botulinum toxin as a treat-ment for spasticity and dystonia in pediatric cerebral palsy. Gac Med Mex 2001;137(5):403-411.
6. Torres J, Pérez-Pérez G, Goodman KJ, Atherton JC, Gold BD, Harris PR, Madrazo-de-la-Garza A, Guarner J, Muñoz O. A comprehensive review of natural history of Helicobacter pylori infection in children. Arch Med Res 2000;31:431-469.
7. Siegel S, Castellán NJ. Medidas de asociación y sus pruebas de significación. Análisis. En: Estadística no paramétrica aplicada a las ciencias de la conducta. México: Trillas: 1995. p. 346-357.
8. Abrahamson JH. ¿How good are the measures? En: Making sense of data. Second edition. New York: Oxford University Press; 1994. p. 153-193.
9. Abrahamson JH. Rates and other measures. En: Making sense of data. Second edition. New York: Oxford University Press; 1994. p. 83-148.
Hassler RG, Christ JF. Parkinson specific motor and mental disorders. Adv Neurol 1984;40:28-96.
Kurtzke JF, Kurland LT. The epidemiology of neurologic disease. En: Baker AB, Baker LH, editors. Clinical neurology. Philadelphia: Harper and Row; 1983. p. 1-143.
Abrahamson JH. Meta-analysis: putting it all together. En: Making sense of date. New York: Oxford Uni-versity Press; 1994. p. 317-389.
Grennland S. Meta-analysis. En: Rothman KJ, Greenland S, editors. Modern epidemiology. Second edition. Philadelphia: Lippincott-Raven Publishers; 1998. p. 643-673.
Le Lorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-542.
Bailer JC. The promise and problems of meta-analysis. N Engl J Med 1997;337:559-561.
Vandenbroucke JP. Evidence-based medicine and observation. J Clin Epidemiol 1996;49:1335-1338.
Evidence-Based Medicine Working Group. Evidence- based medicine. A new approach to teaching the practice of medicine. JAMA 1992;268: 2420-2425.
Sacket D, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71-72.
Benítez-Bribiesca L. Evidence-Based Medicine: A new paradigm? Arch Med Res 1999;30:77-79.
Villacís-Keever MA. Evidence-Based Medicine and quality of care. Arch Med Res 2000;31:110.
Christakis DA, Davis R, Rivera FP. Pediatric evidence-based medicine: past, present, and future. J Pediatr 2000;136:383-384.